1. Home
  2. LVO vs RNAZ Comparison

LVO vs RNAZ Comparison

Compare LVO & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveOne Inc.

LVO

LiveOne Inc.

SELL

Current Price

$2.53

Market Cap

31.9M

ML Signal

SELL

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$1.75

Market Cap

27.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVO
RNAZ
Founded
2009
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
27.9M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
LVO
RNAZ
Price
$2.53
$1.75
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $9.75
N/A
AVG Volume (30 Days)
★ 87.5K
50.3K
Earning Date
11-11-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 78.57
N/A
EPS
★ N/A
N/A
Revenue
★ $77,144,000.00
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$27.12
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.24
$1.52
52 Week High
$7.19
$15.33

Technical Indicators

Market Signals
Indicator
LVO
RNAZ
Relative Strength Index (RSI) 38.16 45.70
Support Level $2.24 $1.55
Resistance Level $5.83 $2.39
Average True Range (ATR) 0.26 0.17
MACD 0.04 0.08
Stochastic Oscillator 41.80 68.29

Price Performance

Historical Comparison
LVO
RNAZ

About LVO LiveOne Inc.

LiveOne Inc creator-first, music, entertainment and technology platform focused on delivering premium experiences and content world-wide through paid users and live and virtual events. It is in the acquisition, distribution and monetization of live music events, Internet radio, podcasting/vodcasting and music-related membership, streaming and video content. It provide services through a dedicated over-the-top application powered by Slacker (LiveOne App) called LiveOne. The company has three operating segments, PodcastOne, Slacker and Media Group. The company generates majority of revenue from PodcastOne. Its operations are based in the United States. It generate revenue through the sale of paid user services and advertising from its music offerings, from the licensing, advertising.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: